Benjamin Burnett
Stock Analyst at Stifel
(1.93)
# 2,976
Out of 4,846 analysts
71
Total ratings
38.78%
Success rate
-8.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $1.30 | +130.77% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $36.95 | +32.61% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $61.90 | +97.09% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $16.19 | +326.19% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $21.22 | +220.45% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.27 | +262.20% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $8.00 | +618.75% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $5.03 | +15,422.39% | 2 | Sep 10, 2021 | |
| BLUE bluebird bio | Upgrades: Buy | $1,880 → $1,400 | $4.97 | +28,069.01% | 3 | Mar 27, 2020 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $40.65 | +57.44% | 5 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $94 | $47.72 | +97.00% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.37 | +191.97% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.33 | +651.88% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.76 | +1,320.45% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $0.80 | +2,913.94% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.47 | +3,283.38% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $1.30
Upside: +130.77%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $36.95
Upside: +32.61%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $61.90
Upside: +97.09%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $16.19
Upside: +326.19%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $21.22
Upside: +220.45%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.27
Upside: +262.20%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $8.00
Upside: +618.75%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $5.03
Upside: +15,422.39%
bluebird bio
Mar 27, 2020
Upgrades: Buy
Price Target: $1,880 → $1,400
Current: $4.97
Upside: +28,069.01%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $40.65
Upside: +57.44%
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $47.72
Upside: +97.00%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.37
Upside: +191.97%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.33
Upside: +651.88%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $1.76
Upside: +1,320.45%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $0.80
Upside: +2,913.94%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.47
Upside: +3,283.38%